Dr. RR Baliga's 'Podkast for the Kurious Doc'
LVAD patients are increasingly encountered in emergency rooms and ICUs, yet many clinicians remain uncertain about initial management. A recent JACC State-of-the-Art Review provides a practical framework for recognizing and treating LVAD emergencies, from pump thrombosis and right-heart failure to arrhythmias and GI bleeding. Key pearls: LVAD patients may lack a palpable pulse, Doppler is preferred for MAP measurement, and Chest compressions should not be delayed if cardiac arrest is confirmed. First check power connection Understanding pump parameters and echocardiographic clues...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
Jiddu Krishnamurti challenged one of humanity’s deepest assumptions—that wisdom must come from teachers, traditions, or systems. Instead, he argued that genuine understanding begins with self-observation and choiceless awareness. In this short slide set, I summarize the life and ideas of Jiddu Krishnamurti (1895–1986)—the thinker who famously declared: “Truth is a pathless land.” 📚 The slides explore: • His early life and break from the Theosophical movement • Core ideas from Freedom from the Known • The role of education and self-inquiry • Why his ideas...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
🧠🦠 Microbes. Metabolites. Memory. A fascinating new Nature study reveals a gut–brain pathway driving age-related cognitive decline. Expansion of Parabacteroides goldsteinii in aging microbiomes increases medium-chain fatty acids, activating GPR84 signaling in peripheral myeloid cells. The resulting inflammation suppresses vagal sensory signaling, blunting hippocampal neuronal activation and impairing memory. Even more intriguing: interventions restoring gut–brain communication improved cognition in mice. This work highlights the gut microbiome as a...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
Lipids remain central to cardiovascular prevention. The 2026 ACC/AHA Dyslipidemia Guideline introduces several important shifts: • PREVENT equations replace older ASCVD risk calculators • Lipoprotein(a) measurement recommended at least once in all adults • ApoB helps identify residual lipoprotein risk • Coronary artery calcium scoring refines treatment decisions • LDL-C targets return, with <55 mg/dL for very high-risk patients • South Asian ancestry is treated as a “risk enhancer,” Earlier identification and aggressive risk reduction remain the...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
🧬🧠❤️ The Immune System Is Not Just Defense — It Is Physiology A superb Science Review (Nahrendorf, Ginhoux, Swirski, 2025) reframes immunity as a systems integrator, shaping brain function, heart rhythm, metabolism, pregnancy, and tissue repair—quietly maintaining homeostasis across the lifespan. Immune cells are not visitors; they are residents, communicators, and regulators in every organ system. 🧩 Defense meets regulation. 🧩 Immunology meets physiology. 📖 Science, August 2025 — a must-read for clinicians, physiologists, and systems thinkers.
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
A fascinating new study reveals a previously underappreciated pathway for tau clearance in the brain. Researchers show that tanycytes—specialized hypothalamic glial cells—actively transport tau from cerebrospinal fluid into the bloodstream. In Alzheimer disease, these cells become fragmented and dysfunctional, impairing tau clearance and potentially accelerating neurodegeneration. This work opens an intriguing avenue: could restoring tanycyte function enhance tau removal and slow Alzheimer progression? A small cellular gatekeeper may hold an important clue in the...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
Obesity is not simply excess weight—it is a metabolic and inflammatory state that can reshape cancer biology. Adipose tissue alters hormones, insulin signaling, inflammatory cytokines, and immune responses, creating conditions that favor tumor development. Evidence now links obesity with cancers of the breast, colon, endometrium, pancreas, liver, kidney, and esophagus. Understanding these mechanisms opens the door to precision prevention strategies, from weight management to metabolic therapies. The message from translational science is clear: metabolism and malignancy are deeply...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
🧬 Apolipoprotein M (ApoM) is emerging as a key regulator of vascular biology. ApoM, an HDL-associated lipocalin, transports sphingosine-1-phosphate (S1P) and selectively activates S1PR1 signaling in endothelial cells. This pathway stabilizes the endothelial barrier, promotes nitric-oxide mediated vasodilation, and suppresses vascular inflammation. Clinical studies increasingly link lower ApoM levels with cardiometabolic disease, CKD, and heart failure risk. New therapies—including ApoM-fusion biologics and selective S1PR1 agonists—may harness this pathway for...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
📚 Simone de Beauvoir (1908–1986) — philosopher, writer, and architect of modern feminism. Her groundbreaking book The Second Sex (1949) reshaped global conversations on gender with one powerful line: “One is not born, but becomes, a woman.” She challenged stereotypes, defended women’s autonomy, and influenced second-wave feminism worldwide. Her ideas still echo in medicine, education, ethics, and leadership today. Freedom. Responsibility. Equality. 💡✊📖
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
🫁 Pulmonary Embolism in 2026 — A Precision Framework The new AHA/ACC Acute Pulmonary Embolism Guideline redefines how we classify and treat PE. Key updates: • Category A–E clinical classification integrating hemodynamics, biomarkers, and RV imaging • Age-adjusted D-dimer and YEARS algorithm to reduce unnecessary imaging • CT pulmonary angiography as preferred diagnostic modality • RV/LV ratio reporting for objective risk stratification • LMWH → DOAC preferred for anticoagulation • Advanced therapies for cardiopulmonary failure • Mandatory 1-year follow-up to screen for...
info_outline1. “Bioaccumulation of Microplastics in Decedent Human Brains” (Nature Medicine, 2024)
This study confirms the presence of microplastics and nanoplastics (MNPs) in human brain tissue, particularly the frontal cortex. Researchers used pyrolysis gas chromatography-mass spectrometry (Py-GC/MS) and electron microscopy to analyze postmortem samples, finding polyethylene (PE) as the dominant plastic type. Brain tissue exhibited significantly higher plastic concentrations than the liver or kidney, with even greater MNP accumulation in individuals diagnosed with dementia. The findings raise concerns about potential neuroinflammation and long-term neurological effects, though causality remains unproven.
2. “Microplastics and Nanoplastics in Atheromas and Cardiovascular Events” (New England Journal of Medicine, 2024)
This study investigates the presence of microplastics in atherosclerotic plaques and their potential role in cardiovascular disease. Analyzing carotid artery plaques from patients undergoing endarterectomy, researchers found polyethylene (PE) and polyvinyl chloride (PVC) in 58.4% of plaques. Patients with MNP-containing plaques had a 4.53 times higher risk of heart attack, stroke, or death over a three-year follow-up. The study also linked MNP presence to elevated inflammatory markers (IL-18, IL-1β, TNF-α, IL-6), suggesting that microplastics might exacerbate cardiovascular disease progression.